Overview

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this observational study is to investigate whether a sufficient concentration of itraconazole can influence disappearance of a fever (defeverscence) when intravenous (into the vein) itraconazole is administered for resolving unknown neutropenic fever of participants who are given itraconazole oral solution as a prophylaxis under general treatment conditions.
Details
Lead Sponsor:
Janssen Korea, Ltd., Korea
Treatments:
Hydroxyitraconazole
Itraconazole